Estimation of Outcome and Quality of Life in ECMO Patients

Launched by HEINRICH-HEINE UNIVERSITY, DUESSELDORF · May 2, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at patients who are receiving a treatment called extracorporeal membrane oxygenation (ECMO), which is used for people with severe heart or lung problems. The study aims to find out how well doctors can predict the outcomes and quality of life for patients on ECMO. While ECMO can be a life-saving treatment, decisions about starting it are often made quickly in emergencies, and the doctors' predictions about how patients will do may not always be accurate. By comparing these predictions with the actual results, researchers hope to improve future care for ECMO patients.

To be part of this study, participants need to be at least 18 years old and have started ECMO therapy within the last 24 hours. They also need to provide written consent, either themselves or through a healthcare representative. The trial is open to all genders, and the primary goal is to gather information to help understand how ECMO impacts patients in terms of survival and quality of life. If you or someone you know is considering ECMO treatment, this study may provide valuable insights that can help guide future medical decisions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age ≥ 18 years
• • start of ECMO therapy ≤24h
• • written informed consent from patient or health-care proxy
• Exclusion Criteria:
• • age \< 18 years
• • Language barrier (communication in German/local language or English not possible).
• • no ECMO therapy or ECMO therapy longer than 24h
• • no written consent